MAYO CLINIC

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1889-01-01

Employees: 10K

Market Cap: -

Website: http://www.mayoclinic.org

Clinical Trials

Low-dose Molecular Breast Imaging: Comparison of Breast Cancer Detection Rate at Initial Screening and Two-year Follow-up

Not Applicable

Terminated

Conditions: Breast Cancer

Interventions: Procedure: Molecular Breast Imaging

First Posted Date: 2012-11-07

Last Posted Date: 2016-09-21

Lead Sponsor: Mayo Clinic

Target Recruit Count: 228

Registration Number: NCT01723124

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma or Newly Diagnosed or Relapsed or Refractory Intraocular Lymphoma

Phase 1

Completed

Conditions: Retinal Lymphoma
Central Nervous System Lymphoma
Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System
B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma
Intraocular Lymphoma
Recurrent Adult Diffuse Large Cell Lymphoma

Interventions: Drug: Dexamethasone
Other: Laboratory Biomarker Analysis
Other: Pharmacological Study
Drug: Pomalidomide

First Posted Date: 2012-11-06

Last Posted Date: 2019-07-22

Lead Sponsor: Mayo Clinic

Target Recruit Count: 29

Registration Number: NCT01722305

Locations: 🇺🇸
Dana-Farber Harvard Cancer Center, Boston, Massachusetts, United States
🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States

and more 4 locations

Collaborative Targeted Case Management in Improving Functional Status in Patients with Stage III-IV Cancer

Not Applicable

Completed

Conditions: Cognitive/functional Effects
Malignant Neoplasm
Pain

Interventions: Behavioral: telephone-based intervention
Other: questionnaire administration
Other: case management
Procedure: physical therapy
Procedure: management of therapy complications
Procedure: quality-of-life assessment
Other: educational intervention
Procedure: assessment of therapy complications

First Posted Date: 2012-11-04

Last Posted Date: 2024-11-21

Lead Sponsor: Mayo Clinic

Target Recruit Count: 516

Registration Number: NCT01721343

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Buparlisib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

Early Phase 1

Completed

Conditions: Recurrent Mantle Cell Lymphoma
Refractory Mantle Cell Lymphoma
Recurrent Grade 3 Follicular Lymphoma
Transformed Recurrent Non-Hodgkin Lymphoma
Recurrent Adult Diffuse Large Cell Lymphoma

Interventions: Drug: Buparlisib
Other: Laboratory Biomarker Analysis
Other: Questionnaire Administration

First Posted Date: 2012-11-01

Last Posted Date: 2018-10-09

Lead Sponsor: Mayo Clinic

Target Recruit Count: 7

Registration Number: NCT01719250

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Cortical Excitability and Inhibition in MDD

Completed

Conditions: Major Depressive Disorder, Recurrent, Mild
Depressive Disorder, Major

Interventions: Device: Transcranial Magnetic Stimulation (TMS)
Device: Magnetic Resonance Spectroscopy and Imaging

First Posted Date: 2012-10-31

Last Posted Date: 2019-10-22

Lead Sponsor: Mayo Clinic

Target Recruit Count: 23

Registration Number: NCT01718730

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Metformin as a Chemoprevention Agent in Non-small Cell Lung Cancer

Phase 2

Terminated

Conditions: Carcinoma, Non-Small-Cell Lung
Lung Neoplasms

Interventions: Other: Placebo Comparator
Drug: Metformin

First Posted Date: 2012-10-30

Last Posted Date: 2020-03-10

Lead Sponsor: Mayo Clinic

Target Recruit Count: 6

Registration Number: NCT01717482

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Effects of Mexiletine on Colonic Transit in a Patient With Irritable Bowel Syndrome - Constipation (IBS-C)

Phase 1

Completed

Conditions: IBS

Interventions: Drug: Mexiletine

First Posted Date: 2012-10-30

Last Posted Date: 2013-10-01

Lead Sponsor: Mayo Clinic

Target Recruit Count: 1

Registration Number: NCT01717404

A Pilot Study to Evaluate the Contribution of the Saphenous Nerve in Ankle Pain of Patients With Degenerative Joint Disease of the Ankle

Terminated

Conditions: Degenerative Joint Disease of the Ankle

First Posted Date: 2012-10-30

Last Posted Date: 2019-04-08

Lead Sponsor: Mayo Clinic

Target Recruit Count: 4

Registration Number: NCT01716650

Locations: 🇺🇸
Mayo Clinic, Jacksonville, Florida, United States

Sleep Apnea and Vascular Function

Not Applicable

Completed

Conditions: OSA

Interventions: Other: Sleep Study

First Posted Date: 2012-10-30

Last Posted Date: 2017-11-13

Lead Sponsor: Mayo Clinic

Target Recruit Count: 45

Registration Number: NCT01717339

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Safety Study of Inhaled Saline in Acute Lung Injury

Phase 1

Withdrawn

Conditions: Pulmonary Edema

Interventions: Drug: Hypertonic Saline Aerosol

First Posted Date: 2012-10-25

Last Posted Date: 2015-08-17

Lead Sponsor: Mayo Clinic

Registration Number: NCT01713595

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy